TANDEM DIABETES CARE

TNDM

Delayed - 02/26 04:00:00 pm
95.99USD	+1.05%

04/29/21	Q1 2021 Earnings Release (Projected)
08/05/21	Interim 2021 Earnings Release (Projected)
11/03/21	Q3 2021 Earnings Release (Projected)
03/02/22	FY 2021 Earnings Release (Projected)

02/24/21 \| 04:30pm	FY 2020 Earnings Call
02/24/21	FY 2020 Earnings Release
11/05/20 \| 04:30pm	Q3 2020 Earnings Call
11/05/20 \| 04:05pm	Q3 2020 Earnings Release

02/26/21 \| 10:40am	ALIGN TECHNOLOGY, INC. : SVB Leerink Global Healthcare Conference
02/26/21 \| 02:20pm	NATERA, INC. : SVB Leerink Global Healthcare Conference
02/26/21	STRAUMANN HOLDING AG : RoadShow - Jefferies
02/26/21 \| 10:40am	NEVRO CORP. : SVB Leerink Global Healthcare Conference

02/25/21 \| 02:25pm	MEDTRONIC PLC : Citigroup Healthcare Services, Medtech, Tools, & HCIT Virtual Conference
02/25/21 \| 11:45am	IDEXX LABORATORIES, INC. : Bank of America Merrill Lynch Virtual Animal Health Summit
02/25/21 \| 09:50am	INSULET CORPORATION : Citigroup Healthcare Services, Medtech, Tools, & HCIT Virtual Conference
02/25/21 \| 08:00am	TELEFLEX INCORPORATED : FY 2020 Earnings Call

Previous year

Next Year

Annual results		2016	2017	2018	2019	2020	2021 (e)
Sales M $	Released Forecast Spread	84,2 86,5 -2,7%	108 98,9 8,8%	184 164 12%	362 363 -0,24%	499 472 5,7%	610
Operating income (EBITDA) M $	Released Forecast Spread	-72,6 -67,9 -6,9%	-59,2 -57,8 -2,4%	-38,8 -41,4 6,2%	-10,7 -12,7 16%	2,49 -5,20 148%	25,2
Operating profit (EBIT) M $	Released Forecast Spread	-78,1 -77,1 -1,3%	-66,1 -67,1 1,5%	-44,6 -56,0 20%	-16,7 -21,0 20%	-7,96 -14,3 44%	12,0
Pre-Tax Profit (EBT) M $	Released Forecast Spread	-83,5 -78,0 -7,0%	-73,0 -76,1 4,0%	-123 -137 11%	-24,6 -29,4 16%	-36,3 -44,9 19%	-1,01
Net income M $	Released Forecast Spread	-83,4 -80,8 -3,2%	-73,0 -77,6 5,8%	-123 -137 11%	-24,8 -29,4 16%	-34,4 -43,3 21%	-0,79
EPS $	Released Forecast Spread	-27,3 -25,2 -8,3%	-12,9 -14,3 10%	-2,55 -2,95 13%	-0,42 -0,50 16%	-0,56 -0,72 22%	0,00
Announcement Date		03/08/2017	03/01/2018	02/26/2019	02/24/2020	02/24/2021

Previous period

Next period

Quarterly results		2018 Q3	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1 (e)	2021 Q2 (e)	2021 Q3 (e)	2021 Q4 (e)	2022 Q1 (e)
Sales M $	Released Forecast Spread	46,3 42,7 8,3%	76,2 56,3 35%	66,0 47,5 39%	93,3 70,0 33%	94,7 89,3 6,0%	108 109 -0,75%	97,9 84,5 16%	109 87,2 25%	124 115 7,3%	168 142 19%	122	138	156	195	145
Operating income (EBITDA) M $	Released Forecast Spread	-14,3 -13,2 -8,2%	2,03 -6,68 130%	-9,56 -11,9 20%	-0,36 -13,6 97%	-4,52 -9,02 50%	3,79 1,37 175%	-11,7 -8,07 -46%	-9,83 -12,0 18%	1,98 -2,82 170%	22,1 13,0 70%	-3,96	1,52	7,49	18,2	10,1
Operating profit (EBIT) M $	Released Forecast Spread	-15,7 -16,3 3,9%	0,56 -10,8 105%	-11,0 -18,3 40%	-1,87 -13,1 86%	-6,00 -10,1 40%	2,14 -2,68 180%	-13,6 -11,4 -19%	-12,0 -15,2 21%	-1,01 -4,84 79%	18,7 12,1 54%	-8,83	-3,17	4,50	19,3	0,55
Pre-Tax Profit (EBT) M $	Released Forecast Spread	-34,2 -18,4 -86%	3,74 -10,7 135%	-23,0 -18,6 -23%	-1,51 -13,2 89%	-2,83 -9,87 71%	2,73 -2,23 223%	-14,8 -11,4 -29%	-29,2 -15,2 -91%	-9,37 -7,71 -22%	17,0 8,41 103%	-11,8	-6,45	1,74	18,4	-1,17
Net income M $	Released Forecast Spread	-34,2 -18,4 -86%	3,69 -10,7 134%	-23,0 -18,8 -22%	-1,51 -13,2 89%	-2,90 -9,97 71%	2,65 -2,74 197%	-14,9 -11,1 -34%	-27,1 -15,4 -76%	-9,41 -5,79 -62%	17,0 7,93 114%	-10,7	-5,35	1,29	16,1	-0,77
EPS $	Released Forecast Spread	-0,62 -0,33 -86%	0,02 -0,19 110%	-0,40 -0,31 -30%	-0,03 -0,24 87%	-0,05 -0,18 73%	0,04 -0,03 220%	-0,25 -0,17 -46%	-0,45 -0,25 -79%	-0,15 -0,12 -29%	0,22 0,12 86%	-0,18	-0,10	0,00	0,23	-0,01
Announcement Date		11/01/2018	02/26/2019	04/30/2019	08/01/2019	11/04/2019	02/24/2020	04/30/2020	07/30/2020	11/05/2020	02/24/2021